Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.48M Buy
182,001
+4,116
+2% +$190K 0.09% 138
2026
Q1
$8.72M Buy
177,885
+6,503
+4% +$302K 0.1% 126
2025
Q4
$7.47M Sell
171,382
-2,633
-2% -$120K 0.1% 128
2025
Q3
$7.83M Buy
174,015
+16,000
+10% +$703K 0.17% 108
2025
Q2
$6.86M Sell
158,015
-182
-0.1% -$8.1K 0.16% 118
2025
Q1
$7.29M Hold
158,197
0.19% 111
2024
Q4
$5.95M Sell
158,197
-15,280
-9% -$593K 0.15% 118
2024
Q3
$7.03M Buy
173,477
+6,821
+4% +$256K 0.19% 110
2024
Q2
$5.77M Buy
166,656
+7,941
+5% +$293K 0.17% 117
2024
Q1
$5.96M Buy
+158,715
New +$5.67M 0.19% 121

Other funds holding EXC

Allianz's EXC Position: Q2 2026 in Review

Allianz increased its Exelon (EXC) stake by 2.3% in Q2 2026, buying an estimated $190K and bringing the position to 182,001 shares worth $8.48M. The position accounts for 0.09% of the portfolio, ranked #138.

Allianz first reported a position in EXC in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.72M in Q1 2026. 1,288 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Allianz held 182,001 shares of Exelon worth $8.48M as of Q2 2026.
  • Allianz bought 4,116 Exelon shares in Q2 2026, an estimated $190K.
  • Exelon made up 0.09% of Allianz's portfolio in Q2 2026, its #138 holding.
  • Allianz first reported a position in Exelon in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Exelon position peaked at $8.72M in Q1 2026.
  • 1,288 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.